Literature DB >> 25578645

Comparison of Renal Parenchymal Volume Preservation Between Partial Nephrectomy, Cryoablation, and Radiofrequency Ablation Using 3D Volume Measurements.

Solomon L Woldu1, Gregory R Thoreson2, Zhamshid Okhunov3, Rashed Ghandour1, Michael B Rothberg1, Arindam RoyChoudhury4, Helen H R Kim5, Mari Bozoghlanian5, Jeffrey H Newhouse6, Mohammad A Helmy5, Ketan K Badani1, Jamie Landman3, Jeffrey A Cadeddu2, James M McKiernan5.   

Abstract

PURPOSE: Small renal masses (SRM) can be managed via a variety of nephron-sparing procedures (NSPs), but the association between choice of NSP and renal parenchymal volume (RPV) preservation is not well understood. We sought to examine RPV preservation after partial nephrectomy (PN) performed via open, robotic, or laparoscopic approaches and thermal ablation (TA) performed via cryoablation (CA) or radiofrequency ablation (RFA). PATIENTS AND METHODS: The study was a retrospective review of three institutional databases of patients with a SRM <4 cm treated via one of the five NSPs (open PN, laparoscopic PN, robotic PN, percutaneous CA, or percutaneous RFA). The 30 most recent consecutive cases treated via each NSP were selected to obtain a total of 150 cases for analysis. Patient characteristics were obtained via manual chart review, and tumor characteristics were assessed via the R.E.N.A.L. nephrometry score. Using three-dimensional rendering software, preoperative and postoperative RPV was calculated for the tumor-bearing kidney, excluding the tumor itself (for preoperative images) or the postsurgical/ablative defect (for postoperative images). The percent change in RPV was compared between the procedure types.
RESULTS: One hundred fifty cases were included in the final analysis, with 30 cases from each NSP category. While preoperative tumors were larger in the PN group, there was no difference in the mean nephrometry score between groups. The TA group was found to have a lower mean RPV loss (-8.1% vs -16.5%, p<0.005). There was no difference in the RPV loss between modalities of TA (CA vs RFA) or between approaches to PN (open, laparoscopic, robotic). Matched-pair analysis based on the tumor size and multivariate analysis indicated TA vs PN was independently associated with less RPV loss.
CONCLUSIONS: TA is associated with less RPV loss than PN in the management of SRM, but there is no difference between modalities of TA (CA vs RFA) or between approaches to PN.

Entities:  

Mesh:

Year:  2015        PMID: 25578645     DOI: 10.1089/end.2014.0866

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  9 in total

Review 1.  Non-Surgical Ablative Therapy for Management of Small Renal Masses-Current Status and Future Trends.

Authors:  K Farrag; S Sriprasad
Journal:  Indian J Surg Oncol       Date:  2016-12-15

Review 2.  Renal Function Following Nephron Sparing Procedures: Simply a Matter of Volume?

Authors:  Michael J Biles; G Joel DeCastro; Solomon L Woldu
Journal:  Curr Urol Rep       Date:  2016-01       Impact factor: 3.092

Review 3.  Ablative Therapies for the Treatment of Small Renal Masses: a Review of Different Modalities and Outcomes.

Authors:  Nicholas Kavoussi; Noah Canvasser; Jeffrey Caddedu
Journal:  Curr Urol Rep       Date:  2016-08       Impact factor: 3.092

Review 4.  [Ablative therapy of small renal masses].

Authors:  M C Kriegmair; N Wagener; S J Diehl; N Rathmann
Journal:  Urologe A       Date:  2018-03       Impact factor: 0.639

5.  Laparoscopic cryoablation for small renal masses: Oncological outcomes at 5-year follow-up.

Authors:  Michaël M E L Henderickx; Annebeth E C Sträter-Ruiter; Alwine E van der West; Harrie P Beerlage; Patricia J Zondervan; Brunolf W Lagerveld
Journal:  Arab J Urol       Date:  2020-12-17

Review 6.  Small renal masses in the elderly: Contemporary treatment approaches and comparative oncological outcomes of nonsurgical and surgical strategies.

Authors:  Malte W Vetterlein; Tarun Jindal; Andreas Becker; Marc Regier; Luis A Kluth; Derya Tilki; Felix K-H Chun
Journal:  Investig Clin Urol       Date:  2016-07-05

7.  Renal functional outcomes after surgery for renal cortical tumors.

Authors:  Danny Lascano; Julia B Finkelstein; G Joel DeCastro; James M McKiernan
Journal:  J Kidney Cancer VHL       Date:  2015-04-04

8.  Percutaneous Cryoablation for Renal Cell Carcinoma.

Authors:  Tsitskari Maria; Christos Georgiades
Journal:  J Kidney Cancer VHL       Date:  2015-06-09

9.  Comparison of Radiofrequency Ablation Versus Cryoablation For T1 Renal Tumors: An Evidence-Based Analysis of Comparative Outcomes.

Authors:  Hongjin Shi; Jinze Li; Zhinan Fan; Jing Yang; Shi Fu; Haifeng Wang; Jiansong Wang; Jinsong Zhang
Journal:  Front Oncol       Date:  2022-04-22       Impact factor: 5.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.